London,Babies Born- July 17, 2025 — In a remarkable medical first, eight babies have been born in the United Kingdom using DNA from three individuals in a cutting-edge procedure designed to prevent devastating mitochondrial diseases. The births mark the first proven success of a pioneering technique aimed at ensuring babies are born free from life-threatening conditions passed down from mothers.
The breakthrough has been led by specialists at the Newcastle Fertility Centre, which has become the world leader in implementing this advanced fertility treatment. While the process has been legal in the UK for nearly a decade, these births provide the first concrete evidence of its success in protecting babies from inherited mitochondrial disorders.
The technique, often referred to as “three-parent IVF,” involves combining the egg and sperm from the biological parents with a second, donated egg from another woman. The goal is to replace faulty mitochondria—the energy-producing structures found in almost all human cells—with healthy ones.
Mitochondria are passed exclusively from mother to child. When these are defective, they can starve the body of energy, leading to severe disabilities, brain damage, heart failure, and in the worst cases, death within days of birth. Approximately one in every 5,000 babies is born with mitochondrial disease, making it a rare but deeply impactful genetic disorder.
The new technique allows for the child to inherit over 99.9% of their DNA from their biological parents, while a tiny fraction—just 0.1%—comes from the donor, specifically in the form of healthy mitochondrial DNA. This change is heritable, meaning it can be passed on to future generations.
Gratitude and Relief from Parents of Babies Born with the Technique
Families who have benefitted from the treatment are choosing to remain anonymous to protect their privacy, but several have issued heartfelt statements through the Newcastle Fertility Centre.
“After years of uncertainty, this treatment gave us hope—and then it gave us our baby,” said the mother of one baby girl. “We look at her now, full of life and possibility, and we’re overwhelmed with gratitude.”
Another parent, whose baby boy was born healthy using the method, echoed those sentiments: “Thanks to this incredible advancement and the support we received, our little family is complete. The emotional burden of mitochondrial disease has been lifted, and in its place is hope, joy, and deep gratitude.”
The method begins by fertilizing both the mother’s and the donor’s eggs with the father’s sperm in a laboratory setting. As the embryos begin to form, scientists extract the parental DNA from one embryo and insert it into another embryo that contains healthy mitochondria but has had its own nuclear DNA removed.
The result is an embryo with the parents’ genetic material and the donor’s healthy mitochondria—thus, a baby who is genetically related to their mother and father but protected from mitochondrial disease.
This revolutionary approach was developed at Newcastle University and the Newcastle upon Tyne Hospitals NHS Foundation Trust, with the NHS officially launching a specialized service in 2017.
According to two new reports published in the New England Journal of Medicine, 22 families have undergone the procedure at the Newcastle Fertility Centre. So far, it has resulted in eight healthy babies—four boys and four girls, including one set of twins—and one ongoing pregnancy.
Professor Bobby McFarland, director of the NHS Highly Specialised Service for Rare Mitochondrial Disorders, said the early results are very encouraging.
“To see the relief and joy in the faces of the parents of these babies after such a long wait and fear of consequences—it’s brilliant to be able to see these babies alive, thriving, and developing normally,” McFarland told the BBC.
All eight babies have been born free from mitochondrial disease and are meeting their expected developmental milestones.
Experts believe this technology could offer hope to families who have previously lost children to mitochondrial disease or who live with the knowledge that future pregnancies could carry the same genetic risk. Many affected families endure the trauma of multiple infant losses before ever receiving a diagnosis or viable treatment option.
The Newcastle team estimates that demand for this procedure could result in 20 to 30 babies born annually through the three-person method, offering a lifeline to parents at risk of passing on mitochondrial conditions.
As science advances and regulatory frameworks adapt, this groundbreaking work is not only reshaping fertility medicine but also rewriting what’s possible for families previously confronted with impossible choices.
Source-BBC
